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Abstract
Background: The RNA polymerase II transcriptional Mediator subunit Med12 is broadly implicated in vertebrate
brain development, and genetic variation in human MED12 is associated with X-linked intellectual disability and
neuropsychiatric disorders. Although prior studies have begun to elaborate the functional contribution of Med12
within key neurodevelopmental pathways, a more complete description of Med12 function in the developing
nervous system, including the specific biological networks and cellular processes under its regulatory influence,
remains to be established. Herein, we sought to clarify the global contribution of Med12 to neural stem cell (NSC)
biology through unbiased transcriptome profiling of mouse embryonic stem (ES) cell-derived NSCs following
RNAi-mediated Med12 depletion.
Results: A total of 240 genes (177 up, 73 down) were differentially expressed in Med12-knockdown versus control
mouse NS-5 (mNS-5) NSCs. Gene set enrichment analysis revealed Med12 to be prominently linked with “cell-to-cell
interaction” and “cell cycle” networks, and subsequent functional studies confirmed these associations. Targeted
depletion of Med12 led to enhanced NSC adhesion and upregulation of cell adhesion genes, including Syndecan
2 (Sdc2). Concomitant depletion of both Sdc2 and Med12 reversed enhanced cell adhesion triggered by Med12
knockdown alone, confirming that Med12 negatively regulates NSC cell adhesion by suppressing the expression
of cell adhesion molecules. Med12-mediated suppression of NSC adhesion is a dynamically regulated process in
vitro, enforced in self-renewing NSCs and alleviated during the course of neuronal differentiation. Accordingly,
Med12 depletion enhanced adhesion and prolonged survival of mNS-5 NSCs induced to differentiate on gelatin,
effects that were bypassed completely by growth on laminin. On the other hand, Med12 depletion in mNS-5 NSCs
led to reduced expression of G1/S phase cell cycle regulators and a concordant G1/S phase cell cycle block without
evidence of apoptosis, resulting in a severe proliferation defect.
Conclusions: Med12 contributes to the maintenance of NSC identity through a functionally bipartite role in
suppression and activation of gene expression programs dedicated to cell adhesion and G1/S phase cell cycle
progression, respectively. Med12 may thus contribute to the regulatory apparatus that controls the balance
between NSC self-renewal and differentiation, with important implications for MED12-linked neurodevelopmental
disorders.
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Background
Development of the mammalian brain is an intricate and
protracted process that initiates with neurulation in the
gastrulating embryo and extends postnatally to struc-
tural and experiential maturation in the adult. This
process involves a highly orchestrated and spatiotempo-
rally restricted series of stages, involving initial neuro-
genesis followed by neuronal migration, differentiation,
synaptogenesis, and establishment of neural connectivity
[1–3]. In parallel, non-neuronal programs, including
gliogenesis, myelination, and angiogenesis complete the
development and maturation processes [4–6]. During
neurogenesis, an initial pool of primary neural stem cells
(NSCs), corresponding to neural tube-derived neuroepi-
thelial cells, undergoes a gradual switch from symmetrical
autoreplicative divisions to asymmetrical neurogenic divi-
sions to produce a progressively restricted set of neural
progenitors that, in turn, specify the final complement of
neuronal subtypes and macroglia that populate individual
brain structures [2, 7, 8]. An appropriate balance between
symmetric (self-renewing) and asymmetric (differentiative)
cell divisions is critical to ensure maintenance of an
adequate pool of founder progenitors as well as the proper
number and distribution of their more fate-restricted de-
rivatives, all of which contribute to the final neuronal out-
put. The choice between self-renewal and differentiation
is largely determined by programmed gene expression
changes, many at the transcriptional level, in response to
signals propagated by autocrine, paracrine, and exocrine
soluble factors, as well as cell-cell and cell-matrix interac-
tions [9–12]. Accordingly, genetic or environmental per-
turbations that disrupt physiologic transcription controls
can alter NSC fate leading to neurodevelopmental defects.
In metazoans, signal-dependent developmental regula-
tion of RNA polymerase II (Pol II) transcription requires
Mediator, a conserved multi-subunit signal processor
through which regulatory information conveyed by
gene-specific transcription factors is transduced to Pol
II. Functionally, Mediator acts to control and coordinate
multiple steps in the transcription process, including
pre-initiation complex (PIC) formation through chroma-
tin reconfiguration and Pol II recruitment, early initi-
ation events linked to Pol II promoter escape, Pol II
pausing and elongation, and co-transcriptional RNA
processing [13–18]. Structurally, Mediator is assembled
from multiple constituent subunits (30 in mammals)
arranged into 4 distinct modules, including “head”,
“middle”, “tail”, and a dissociable 4-subunit “kinase”
module comprising Med13, Med12, Cyclin C (CycC),
and Cdk8 (or its mutually exclusive paralog Cdk19)
[19–23]. Within the kinase module, Med12 is a crit-
ical transducer of regulatory information conveyed by
signal-activated transcription factors linked to diverse
pathways critical for proper brain development and
function, including the Sonic hedgehog, Wnt, Notch,
and EGF pathways, among others [24–28]. Notably,
Med12 is an obligate activator of CycC-dependent
Cdk8/19 in Mediator, and Med12-mediated signaling
can therefore occur in a manner dependent or inde-
pendent of Cdk8/19 [13, 28–31].
Because of its critical role as an endpoint in key devel-
opmental signaling pathways, Med12 is broadly impli-
cated in vertebrate neural development. In zebrafish,
Med12 has been shown to be required for proper devel-
opment of the brain and neural crest where it plays an
essential role in the production of monoaminergic neu-
rons and cranial sensory ganglia through selective regu-
lation of neuronal-specific gene expression [32–34].
More recently, Med12 was shown to be required for
hindbrain boundary formation and a notable reduction
of cell proliferation was found in the hindbrain of
Med12 mutant zebrafish [35]. Studies in hypomorphic
Med12 mutant mouse embryos revealed that Med12 is
essential for early mouse development and required for
neural tube closure and axis elongation, which is likely
to be caused by the disruption of the Wnt/β-catenin and
Wnt/planar cell polarity (PCP) signaling [36]. Finally, in
humans, genetic variation in MED12 is associated with
cognitive and behavioral dysfunction. For example, poly-
morphisms in the MED12 C-terminus have been linked
with neuropsychiatric illness, including schizophrenia
and psychosis [37–39]. Furthermore, missense mutations
in MED12, located on Xq13, have been shown to be
causative for a growing number of X-linked intellectual
disability (XLID) disorders, including FG (or Opitz-
Kaveggia), Lujan-Fryns (or Lujan), and Ohdo (MKB
type) syndromes [40–42]. Recent molecular genetic and
biochemical studies have uncovered key developmental
signaling pathways dysregulated as a consequence of
these pathogenic mutations in MED12, suggesting pos-
sible bases to explain at least some of the clinical pheno-
types associated with these developmental disorders. In
this regard, MED12 mutations linked with FG, Lujan
and Ohdo syndrome have all been shown to disrupt epi-
genetic repression of neuronal gene expression imposed
by the RE1 silencing transcription factor/neural restrict-
ive silencer factor (REST/NRSF), a master regulator of
neuronal fate [13, 29, 42]. Furthermore, MED12 muta-
tions linked with FG and Lujan syndromes were shown
to disrupt a Mediator imposed constraint on GLI3-
dependent SHH signaling [27, 28]. Nonetheless, a more
complete description of Med12 function in the develop-
ing nervous system, including the specific biological
networks and cellular processes under its regulatory in-
fluence, remains to be firmly established. With this goal
in mind, we herein combined targeted Med12 depletion
with global transcriptome profiling in mouse NSCs
(mNSCs). These studies reveal a functionally bipartite
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role for Med12 in the concurrent suppression and activa-
tion of gene expression programs dedicated to cell adhe-
sion and G1/S phase cell cycle progression, respectively,
thus revealing an unexpected role for Med12 in the
enforcement of two genetic programs critical to mainten-
ance of the NSC state.
Results
Med12 regulates NSC gene expression programs linked
to adhesion and cell cycle progression
To investigate the global contribution of Med12 to NSC
biology, we profiled the transcriptomes of mouse NS-5
(mNS-5) NSCs following RNAi-mediated Med12 deple-
tion. The mNS-5 cell line is a clonal embryonic stem
(ES) cell-derived adherent neural stem cell line that is
self-renewing, genetically stable, and multipotent with
the capacity to differentiate into neurons and glia both
in vitro and in vivo [43, 44]. mNS-5 NSCs were
employed for transcriptome profiling in an effort to
facilitate identification of target genes likely to mediate
the function of Med12 in neural development. To this
end, parallel cultures of mNS-5 NSCs were infected with
lentiviruses expressing either non-silencing control or
Med12-specific shRNAs. We validated efficient Med12
knockdown (40–60 %) at both the mRNA and protein
levels by RT-qPCR and immunoblot analyses, respect-
ively (Additional file 1: Figure S1A and B). Biotin-labeled
cRNA probes synthesized from control and Med12
knockdown cells (n = 3) were hybridized onto Illumina
MouseWG-6 BeadChip microarrays containing 45,281
unique transcript probes corresponding to >20,000 mouse
genes. Genes with a False Discovery Rate (FDR)-adjusted
p-value of p ≤ 0.05 and fold change ≥2 were considered
differentially expressed upon MED12 depletion.
Using these criteria, a total of 240 genes were dif-
ferentially expressed upon Med12 depletion in mNS-
5 NSCs (Additional file 2: Table S1); 177 genes
(74 %) were upregulated, while 63 genes (26 %) were
downregulated. To validate primary data derived
from microarray analysis, we profiled the expression
levels of 29 randomly selected genes (25 upregulated,
4 downregulated) using the same RNA samples
subjected to microarray analysis as well as RNA
from an independent set of knockdown experiments
(Additional file 1: Figure S1C and D). The results of
this analysis were fully concordant with the micro-
array data regarding the direction and extent of
regulation for each gene.
To gain insight concerning the possible biological
functions of Med12 in NSCs, we subjected the list of
genes differentially expressed in Med12 knockdown
cells to Ingenuity® Pathway Analysis (IPA®). The most
prominent molecular networks and cellular functions
to emerge from this analysis included “cell-to-cell
signaling and interaction”, “gene expression”, and “cell
cycle” (Table 1). In addition, these genes are
Table 1 Top networks and biological functions of Med12 regulated genes in mNSC
Top networks Score
Cell-to-cell signaling and interaction, Connective tissue development and function, Cellular movement 48
Gene expression, Cell cycle, Connective tissue development and function 38
Dermatological disease and condition, Genetic disorder, Gene expression 27
Cell-to-cell signaling and interaction, Cardiac Necrosis/Cell Death, Cell death 26
Psychological disorders, Connective tissue development and function, Gene expression 22
Disease and disorders p-value # Genes
Cancer 3.02E-05–2.03E-02 56
Genetic disorder 1.93E-04–1.88E-02 95
Endocrine system disorders 2.17E-04–1.83E-02 39
Metabolic disease 2.17E-04–1.83E-02 39
Hematological disease 8.26E-04–1.83E-02 3
Molecular and cellular functions p-value # Genes
Cell-to-cell signaling and interaction 3.49E-07–1.88E-02 23
Gene expression 2.60E-05–2.03E-02 15
Cell cycle 6.34E-05–1.95E-02 13
Cellular development 8.42E-05–2.03E-02 39
Cellular movement 1.03E-04–1.98E-02 29
Ingenuity® Pathway Analysis (IPA®) was used to analyze microarray data to gain insight of putative function of Med12 in mNSC. The significance of representation
(p-value) is determined by IPA based on the number of genes found in each biological category divided by the number of known genes assigned to that category
by the Ingenuity® Knowledge Base
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prominently linked to “cancer” and “genetic disorders”
(including “psychological disorders”) (Table 1), con-
sistent with the established roles of MED12 as a both
cancer driver and a XLID gene [13, 39, 45–47]. While
the generic association between Med12 and “gene ex-
pression” revealed by IPA is fully consistent with the
well-characterized role of Med12 as a coregulator of
signal-controlled transcription factors, the association
of Med12 with “cell-to-cell interaction” and “cell
cycle” networks, two genetic programs critical to the
NSC phenotype, was unexpected. We therefore sought
to explore the involvement of MED12 in these two
cellular processes.
Med12 suppresses NSC adhesion by repressing the
expression of cell adhesion molecules
Among Med12-regulated genes linked by IPA to the
“cell-to-cell interaction” network, most were upregulated
following Med12 knockdown, suggesting that Med12
might normally function to suppress a gene expression
program dedicated to NSC interaction and adhesion
(Fig. 1; Additional file 2: Table S1). To investigate this
possibility, we monitored the impact of Med12 knock-
down on the adhesive properties of mNS-5 NSCs as well
as the expression levels of network genes considered
likely to be direct effectors of cell adhesion, including
the extracellular matrix (ECM) and/or cell membrane
Fig. 1 Med12 mediates suppression of genes involved in “Cell Adhesion”. Functional gene interaction networks were identified by IPA®. Genes
are represented as nodes, and the biological relationship between two nodes is represented as a line. The color of the node indicates up- or
down- regulation (red, up; green, down); uncolored nodes represent genes that were not identified as differentially expressed in our microarray,
but have nonetheless been integrated into the computationally generated networks on the basis of the evidence stored in the IPA knowledge
memory indicating a relevance to this network
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protein-encoding genes Laminin alpha 3 (Lama3), Laminin
gamma 1 (Lamc1), Secreted acidic cysteine rich glycopro-
tein (Sparc), Syndecan 2 (Sdc2), and Integrin beta 5
(Itgb5). To distinguish between Cdk8-dependent and
Cdk8-independent functions for Med12 in the possible
regulation of cell adhesion, we additionally monitored the
impact of Cdk8 knockdown on mNS-5 NSC adhesion and
gene expression. To this end, mNS-5 NSCs infected with
lentiviruses expressing control, Med12-, or Cdk8-specific
shRNAs were comparatively evaluated using a quantitative
flourometric-based cell adhesion assay (Calcein AM). We
validated efficient depletion of Med12 and Cdk8 proteins
in these experiments by immunoblot analysis of virally in-
fected cell extracts (Additional file 3: Figure S2). Com-
pared to control knockdown, Med12 knockdown
enhanced mNS-5 cell adhesion by approximately 3.5 fold
(Fig. 2a). By contrast, Cdk8 knockdown had no measur-
able impact on mNS-5 cell adhesion (Fig. 2a). As ex-
pected, we confirmed enhanced expression of cell
adhesion genes (Lamc1, Itgb5, Sdc2, Sparc) upon Med12
depletion, while Cdk8 knockdown was without effect
(Fig. 2b). These results validate both microarray and IPA
analyses and, more importantly, implicate Med12 in the
regulation of NSC adhesion, likely through Cdk8-
independent suppression of a cell adhesion gene expres-
sion program.
To confirm this possibility, we asked whether enhanced
mNS-5 cell adhesion observed upon Med12 depletion
could be functionally reversed by concurrent deple-
tion of cell adhesion molecules regulated by Med12.
Accordingly, mNS-5 cells were co-infected with lenti-
viruses expressing control or Med12-specific shRNAs
along with individual lentiviruses expressing shRNAs
specific for either Itgb5 or Sdc2 prior to harvest and
assay for cell adhesion. Strikingly, concomitant deple-
tion of both Sdc2 and Med12 effectively reversed
enhanced cell adhesion triggered by Med12 knock-
down alone, thus confirming that Med12 regulates
NSC adhesive properties by suppression of cell adhe-
sion genes (Fig. 2c).
mNS-5 NSCs are multipotent adherent neural stem
cells capable of self-renewal in the presence of growth
factors, including EGF and FGF-2, and growth on gel-
atin. This cell line can be directed to differentiate along
the neuronal lineage by sequential removal of growth
factors as well as a change in substratum from gelatin to
laminin that reflects the involvement of cell-cell and
cell-matrix interactions in the neuronal differentiation
process [43]. We sought to determine whether Med12-
imposed suppression of cell adhesion genes in self-
renewing NSCs cells is subject to regulation during
neuronal differentiation. To this end, we first investi-
gated whether cell adhesion genes actively repressed by
Med12 in proliferating mNS-5 cells undergo changes in
their respective expression levels during in vitro neur-
onal differentiation. For this purpose, mNS-5 cells were
seeded onto laminin-coated plates and induced to differ-
entiate along the neuronal lineage by sequential with-
drawal of growth factors from the culture medium.
RNAs were harvested on Day 0, 2, 5, 8, and 11 following
initiation of neuronal differentiation, and the expression
levels of cell adhesion genes were monitored by RT-
qPCR. Strikingly, four out of five analyzed cell adhesion
genes actively suppressed by Med12 in proliferating
mNS-5 NSCs, including Sdc2, Itgb5, Sparc, and
Lama3, were dramatically upregulated during the
Fig. 2 Med12 depletion enhances NSC adhesion in a manner reversible by concurrent depletion of Sdc2. a mNS-5 NSCs infected with lentiviruses
expressing non-specific (NS) control, Med12-, or Cdk8-specific shRNAs were harvested and incubated with Calcein-AM prior to seeding onto 96-well
plates. After washing, adherent cells were detected by fluorometry. The percentage of adhesion was calculated by dividing the background-subtracted
fluorescence of adherent cells by the total corrected fluorescence of cells added to each well and multiplying by 100. b RNA from mNS-5 NSCs infected
with lentiviruses expressing NS control, Med12-, or Cdk8-specific shRNAs as indicated were used for RT-qPCR, mRNA levels for each gene were normalized
to β-actin mRNA and expressed relative to their corresponding mRNA levels in NS control shRNA-expressing cells. c mNS-5 NSCs co-infected with
lentiviruses expressing shRNAs specific for Med12 or the indicated cell adhesion genes were assayed for cell adhesion as described in (a). 7All data
represent the mean +/− SEM of at least three independent experiments performed in triplicate. p values were calculated by Student’s t test
Kim et al. BMC Developmental Biology  (2016) 16:17 Page 5 of 15
course of neuronal differentiation, which was con-
firmed by expression of the neuronal marker Tuj1
(Fig. 3). A minimal increase in Lamc1 expression,
while reproducibly observed during neuronal differen-
tiation, nonetheless failed to achieve statistical signifi-
cance. Notably, the expression level of Med12 itself
was significantly, albeit minimally, upregulated during
neuronal differentiation. This observation excludes the
possibility that neurogenic expression of Med12-
targeted cell adhesion genes derives from extinction
of Med12 expression during differentiation, and
instead indicates dynamic regulation of Med12-
mediated suppression. Apparently, alleviation of a
Med12-imposed block to the expression of cell adhe-
sion genes in self-renewing NSCs is required for, or
consequent to, NSC cell differentiation.
To begin to clarify this issue, we asked whether
Med12 depletion would permit the promiscuous dif-
ferentiation of NSCs on a limiting (gelatin) substra-
tum otherwise non-permissive for differentiation. To
this end, mNS-5 NSCs infected without (mock) or
with lentiviruses expressing control, Med12-, or
Cdk8-specific shRNAs were plated onto gelatin or
laminin substrata prior to induction of neuronal dif-
ferentiation by sequential withdrawal of growth fac-
tors. Changes in cell morphology and adhesion were
monitored during the course of differentiation by op-
tical microscopy and Calcein AM-based cell adhesion
assay as described previously. Notably, when induced
to differentiate on gelatin, Med12 knockdown cells,
compared to mock-infected or control-knockdown
cells, exhibited enhanced cell adhesion (~7-fold) and
prolonged survival, although these cell failed to
complete neuronal differentiation (Fig. 4a and b). On
the other hand, enhanced cell adhesion and survival
on gelatin triggered by Med12 knockdown was
completely bypassed by induction of mNS-5 NSC
differentiation on laminin. Thus, compared to mock-
infected or control-knockdown cells, Med12-knockdown
cells exhibited no significant differences in cell morph-
ology or adhesion (Fig. 4c and d). These findings suggest
that reversal of a Med12-mediated block to the expression
of cell adhesion genes is a regulated process that may be
required as a course of NSC differentiation along the
neuronal lineage.
Med12 promotes NSC proliferation through activation of
G1/S phase cell cycle regulatory genes
Among Med12-regulated genes linked by IPA to the
“cell cycle”, most were downregulated following Med12
depletion (Fig. 5; Additional file 2: Table S1). Notably,
several of these genes, including Ccne2, E2f2, E2f3, Jun,
Fig. 3 Expression of Med12-regulated cell adhesion genes increases during neuronal differentiation of mNS-5 NSCs. mNS-5 NSCs were seeded onto
laminin-coated plates prior to initiation of neuronal differentiation by sequential withdrawal of growth factors as indicated in the schematic and
described in Methods. RNA isolated from cells on 0, 2, 5, 8, and 11 days after initiation of neuronal differentiation was subjected to RT-qPCR. mRNA
levels for each gene were normalized to β-actin mRNA and expressed relative to their corresponding mRNA levels on day 0 (D0′) of the differentiation
protocol. Data represent the mean +/− SEM of three independent experiments performed in triplicate. Asterisks denote statistically significant
differences in the relative mRNA levels for each gene compared to their corresponding levels on D0′ (Student’s t test, **p < 0.05, ***p < 0.01)
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and Egr1, encode established G1/S phase cell cycle regu-
lators, suggesting that in proliferating NSCs, Med12
might normally function to activate a gene expression
program involved in G1/S phase cell cycle progression.
To examine this possibility, we monitored the impact of
Med12 knockdown on the cell cycle distribution profile
of proliferating mNS-5 NSCs. Thus, asynchronously
growing mNS-5 NSCs were infected with lentiviruses
expressing control, Med12-, or Cdk8-specific shRNAs
prior to analysis of DNA content by flow cytometry.
This analysis revealed that depletion of Med12, but not
Cdk8, significantly increased the percentage of G1-phase
cells while simultaneously decreasing the percentage of
S-phase cells, indicative of a G1/S phase cell cycle block
(Fig. 6a). By contrast, Med12 depletion had no
significant impact on mNS-5 apoptotic cell death
(Fig. 6b). To determine if the observed G1/S phase cell
cycle block accompanying Med12 knockdown is mani-
fest in a proliferative defect, we monitored the impact
of Med12 knockdown on mNS-5 proliferation by
viable cell counting. Compared to control-knockdown
cells, Med12-knockdown cells exhibited a significant
(~2.5-fold) reduction in cell proliferation (Fig. 6c). By con-
trast, knockdown of neither Cdk8 nor Med1, a different
subunit localized to the middle module of Mediator, ad-
versely affected cell proliferation (Fig. 6c). Notably, how-
ever, knockdown of CycC recapitulated the impact of
Med12 depletion (Fig. 6c). Because CycC links Cdk8/19 to
Med12 in the Mediator kinase module, the requirement
for Med12 and CycC, but not Cdk8, implies a probable
Fig. 4 Med12 knockdown increases cell adhesion and preserves cell viability on limiting (gelatin) substratum during neuronal differentiation. a-d
mNS-5 NSCs infected with lentiviruses expressing NS control, Med12-, or Cdk8-specific shRNAs were seeded into T-75 tissue culture flasks coated
with gelatin (a, b) or laminin (c, d) prior to initiation of neuronal differentiation as described in Fig. 3. Fluorescence based adhesion assay (a, c)
was performed 40 h after initiation of the neuronal differentiation. Data represent the mean +/− SEM of at least three independent experiments
performed in triplicate. p values were calculated by Student’s t test. Brightfield images (b, d) were obtained by optical microscopy at 1, 4, and
7 days after initiation of neuronal differentiation. e and f Validation of Med12 and Cdk8 depletion in knockdown cells by RT-qPCR (e) and
immunoblot (f) analyses. mRNA levels for each gene in (e) were normalized to β-actin mRNA and expressed relative to their corresponding mRNA
levels in untreated (MOCK) cells. Data represent the mean +/− SEM of at least three independent experiments performed in triplicate. p values were
calculated by Student’s t test
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role for Cdk19 in mNS-5 NSC proliferation. As expected,
we confirmed significant downregulation in these experi-
ments of G1/S phase cell cycle regulators, including
Ccne2, E2f2, E2f3, and Jun, following depletion of Med12
and CycC, but not Cdk8 or Med1 (Fig. 6d). Furthermore,
by targeted small-scale gene expression profiling in mNS-
5 NSCs, we identified an expanded set of apparent
Med12-dependent G1/S phase cell cycle regulators. Thus,
Ccnd3, E2f4, Ccna2, and Ccne1 were all specifically down-
regulated following Med12 depletion (Fig. 6e). Notably,
neither p21 nor p27 expression levels were altered by
Med12 depletion, excluding DNA-damage and/or restric-
tion checkpoints as possible bases for the G1/S phase cell
cycle block observed in Med12-knockdown cells. Instead,
these findings suggest that Med12 promotes NSC prolifer-
ation through Cdk8-indpendent, but possibly Cdk19-
dependent, activation of a G1/S phase cell cycle regulatory
gene expression program.
Discussion
Although recent studies have begun to elaborate the
involvement of Med12 in the developing vertebrate ner-
vous system, much less in known regarding the precise
functions of this important Mediator subunit at the
cellular level. In an initial effort to address this know-
ledge gap, we herein combined Med12 knockdown with
global transcriptome profiling in mouse ES cell-derived
NSCs. Our findings reveal novel roles for Med12 in the
Fig. 5 Med12 mediates activation of genes involved in “Cell Cycle Control”. Genes involved in cell cycle control are largely downregulated (green)
upon Med12 depletion in mNS-5 NSCs. Functional gene interaction networks were identified by IPA® as described in Fig. 1
Kim et al. BMC Developmental Biology  (2016) 16:17 Page 8 of 15
control of NSC adhesion and cell cycle progression, both
of which are known to be fundamentally associated with
stem cell maintenance. Previous studies have indicated
that interactions between NSCs and their niche play an
essential regulatory role in balancing stem cell mainten-
ance and differentiation [48, 49]. Moreover, studies have
suggested that ECM, a major niche component, plays a
key regulatory function in NSC maintenance and differ-
entiation by transferring environmental cues to embry-
onic and adult NSCs [50–55]. For instance, in the
developing mammalian embryonic brain, loss of the
adhesion molecule Integrin promotes neural stem cell
detachment from the ECM and ultimately apoptosis
[56]. Laminins are the best-described ECM component
and laminin γ1 has been shown to be associated with
NSC differentiation in the mouse [57]. In addition, stud-
ies have suggested that cell adhesion molecules may
influence asymmetric stem cell division by interacting
with microtubules of the mitotic spindle and directing
the plane of cell division [58]. Thus, while the contribu-
tion of cell adhesion molecules to NSC homeostasis is
well established, it is less clear how these molecules are
transcriptionally regulated. We found that Med12 deple-
tion enhanced NSC adhesion concordant with upregula-
tion of cell adhesion genes, including those encoding
ECM components, integrins, and proteoglycans. Further-
more, concurrent reduction of both Sdc2 and Med12
was sufficient to partially reverse enhanced cell adhesion
triggered by Med12 knockdown alone, confirming that
Med12 negatively regulates NSC cell adhesion by tran-
scriptional suppression of cell adhesion molecules. Not-
ably, we observed that cell adhesion genes suppressed by
Med12 in proliferating NSCs were upregulated during
directed neuronal differentiation in vitro, thus revealing
Med12-imposed suppression to be a dynamically regu-
lated process. In support of this, depletion of Med12
Fig. 6 Med12 depletion reduces mNS-5 NSC proliferation likely through a G1/S phase cell cycle block. a-e mNS-5 NSCs were infected with
lentiviruses expressing NS control, Med12-, Med1-, Cdk8-, and/or CycC (Ccnc)-specific shRNAs as indicated. a Five days post-infection, cells
were harvested, fixed, and monitored for cell cycle distribution using a FACSCalibur flow cytometer and CellQuest Pro software prior to
data analysis using FlowJo software. At least 10,000 single cell events were collected for the analysis. b Five days post-infection, cells were
stained with annexin V conjugated to APC and propidium iodide. Stained cells were analyzed by FACSCalibur and data was analyzed
using FlowJo software. c Lentivirus-infected cells were seeded at a concentration of 5 × 104 cells/well in 12-well plates. Cell proliferation
was monitored by counting viable cells using 0.4 % trypan blue at 24, 48, 72, and 96 h post-seeding. d, e mRNA expression levels for
the indicated genes were determined by RT-qPCR analyses as described in Fig. 2. mRNA levels for each gene were normalized to Gapdh
mRNA and expressed relative to their corresponding mRNA levels in control NS shRNA-expressing cells. All data represent the mean +/− SEM of at
least three independent experiments performed in triplicate. p values were calculated by Student’s t test. Asterisks denote statistically
significant differences relative to NS control shRNA (*p < 0.1, **p < 0.05, ***p < 0.01)
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alone was sufficient to promote enhanced adhesion and
prolonged survival of NSCs induced to differentiate on a
limiting (gelatin) substratum otherwise nonpermissive
for neuronal differentiation. By contrast, directed differ-
entiation of NSCs on a permissive (laminin) substratum
completely bypassed the adhesion and survival advan-
tage conferred by Med12 depletion. Taken together,
our findings support the notion that Med12 contrib-
utes to maintenance of the NSC state through sup-
pression of a cell adhesion program and, furthermore,
that this suppression is alleviated as a course of neur-
onal differentiation.
During neural development, NSCs undergo symmetric
and asymmetric divisions, the former to maintain an ad-
equate founder progenitor pool and the latter to ensure
an appropriate number and distribution of more fate-
restricted progeny. Cell fate decisions are tightly associ-
ated with the cell cycle machinery [59, 60]. Cell cycle
progression is controlled by checkpoints at each phase
of the cell cycle by a series of highly regulated events,
including the alternating activities of various cyclin-
dependent kinases (CDKs). CDKs are activated only
upon binding to their corresponding cyclin(s) and re-
pressed by CDK inhibitors [61]. Previous studies have
indicated that down-regulation of cyclins acting at the
G1 and S phases of the cell cycle prevents S phase entry
and favors withdrawal from the cell cycle [62]. Our find-
ings revealed that Med12 depletion leads to down-regu-
lation of G1/S cell cycle regulators, triggering a G1/S
phase cell cycle block and diminished NSC prolifera-
tion. Although our results clearly indicate that Med12
plays a role in NSC proliferation, it is presently un-
clear whether Med12 plays a role in NSC self-
renewal. In this regard, it is well established that
mechanistic control of cell cycle progression is tightly
linked with NSC proliferation and differentiation in
the embryonic and adult nervous system [63]. For ex-
ample, the G1 phase (restriction) check point, beyond
which cells are irreversibly committed to replication
absent external growth stimuli, represents a funda-
mental step in regulating stem cell self-renewal and
differentiation, while G1 phase duration directly influ-
ences the differentiation of neural precursors [64–67].
Thus, Med12 may prevent unscheduled NSC differen-
tiation by activating G1/S phase cell cycle regulators
and promoting G1/S phase cell cycle transit.
Med12 is an obligate activator of CycC-dependent
Cdk8 in Mediator, and Med12 may therefore control
gene expression in a manner dependent or independent
of Cdk8 kinase activity [13, 28, 29]. Herein, we found
that Med12 regulates NSC adhesion and cell cycle regu-
latory genes in a Cdk8-independent manner. However,
this does not exclude the possibility that Med12-
mediated gene regulation in this setting is dependent on
Mediator-associated kinase activity. In fact, our observa-
tion that CycC depletion effectively recapitulates the
impact of Med12 knockdown supports a probable role
for Med12-dependent Cdk19 activity in this context,
since CycC physically links Med12 with Cdk8/19 and
Cdk8 is functionally dispensable for Med12-dependent
control of mNS-5 proliferation and cell cycle regulatory
gene expression. Notably, Cdk19 is expressed in the
developing nervous system, and we found that Cdk19 is
indeed expressed in mNS-5 NSCs. Cdk8 and Cdk19
share 91 % overall amino acid sequence identity, with a
particularly high degree of sequence conservation in
their respective kinase and cyclin-binding domains, but
considerably more divergence in their corresponding C-
termini [68]. These paralogous subunits assemble into
Mediator in a mutually exclusive manner, and recent
studies have revealed that Cdk8-Mediator and Cdk19-
Mediator are not functionally redundant during develop-
ment [13, 69]. In fact, these distinct Mediator species
regulate unique gene expression programs in some cel-
lular settings [68–70]. Accordingly, further studies will
be required to establish whether and how Cdk19 con-
tributes to Med12-dependent regulation of cell adhesion
and cell cycle regulatory genes in mNS-5 NSCs.
Finally, the mechanism by which Med12 differentially
represses and activates cell adhesion and cell cycle regu-
latory programs remains to be fully clarified. In this
regard, we and others have shown that Med12 can func-
tion in a context-dependent manner as either a co-
activator or co-repressor of gene transcription [24, 28,
29, 71]. For example, we previously showed that MED12
is co-activator of Wnt-stimulated β-catenin; in this con-
text, Pol II is indirectly recruited by promoter-bound
LEF/β-catenin through Mediator, with which β-catenin
interacts directly through its MED12 interface [24]. By
contrast, we have also shown that MED12 is a co-
repressor of REST/NRSF in neuronal gene silencing
through a mechanism involving epigenetic repression. In
this context, the MED12 interface in Mediator links
promoter-bound REST/NRSF with G9a histone methyl-
transferase, a dominant euchromatic H3K9 dimethylase
in mammalian cells [29, 72]. It thus appears likely that
Med12 mediates suppression and activation of cell adhe-
sion and cell cycle regulatory genes, respectively, through
a mechanism involving differential recruitment by gene-
specific regulators. In this regard, it is notable that Rest/
Nrsf has previously been implicated in the regulation of
an ECM gene expression program in mouse NSCs [73].
However, in this context, Rest/Nrsf appears to be required
for activation of ECM genes, and therefore functionally
opposed to the role of Med12 identified herein as a sup-
pressor of ECM and cell adhesion genes. Further studies,
including those in primary brain-derived NSCs, will be re-
quired to establish the precise and broader conserved
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regulatory mechanism(s) by which Med12 differentially
functions to suppress and activate cell adhesion and cell
cycle control programs in NSCs.
Conclusions
Collectively, our findings reveal new insight concerning
the global contribution of Med12 to NSC biology. We
propose a model in which Med12 contributes to main-
tenance of NSC identity by concurrent suppression and
activation of gene expression programs dedicated to cell
adhesion and G1/S phase cell cycle progression, respect-
ively (Fig. 7). In this capacity, Med12 may contribute to
the balance between NSC self-renewal and differenti-
ation. Future studies will seek to clarify the mechanistic
bases by which Med12/Mediator integrates and trans-
duces regulatory signals that specify its dual functional-
ity in suppression and activation of gene expression
programs that contribute to NSC fate.
Methods
Mouse NSC maintenance and neuronal differentiation
mNS-5 cells (a kind gift form Dr. Austin Smith, Well-
come Trust Medical Research Council Stem Cell Insti-
tute, University of Cambridge, UK) were cultured as
described [41]. Briefly, cells were maintained on 0.1 %
(v/v) gelatin-coated tissue culture plates in RHB-A
media (StemCells, Inc., Newark, CA, USA) supple-
mented with FGF-2 (10 ng/ml; Peprotech, Rocky Hill,
New Jersey, USA), EGF (10 ng/ml; Peprotech) and L-
glutamine (2 mM; Invitrogen, CA, USA), penicillin (100
units/ml; Invitrogen, CA, USA), streptomycin (100 ug/ml;
Invitrogen). The cells were maintained in 5 % CO2 incu-
bator at 37 °C. Accutase (Sigma-Aldrich, St Louis, MO,
USA) was used for passaging.
Neuronal differentiation was achieved through with-
drawal of growth factors sequentially on laminin substra-
tum. Cells were plated on poly-ornithine/laminin coated
tissue culture plate in RHB-A medium supplemented
with 5 ng/ml FGF-2. Medium was replaced every 2–3
days during the differentiation. After 7 days, the medium
was changed to RHB-Basal medium mixed with Neural
Basal Media (1:1) (GIBCO) supplemented with ¼N2
and B27 (GIBCO) without growth factors.
Lentivirus-mediated RNAi
shRNA transfer vectors were purchased from Sigma
(Sigma; catalog numbers: shControl- SHC002, shMed12-
TRCN0000096467, shCdk8- TRCN0000023107, shCy-
clinC- TRCN0000077830, shMed1- TRCN0000099578,
shLamc1- TRCN0000055420, shSdc2- TRCN0000311814,
Itgb5- TRCN0000067123). Each lentiviruses were pro-
duced by transient cotransfection of HEK293T cells with
shRNA transfer vectors with pMD2G and psPAX2
(AddGene) using X-tremeGENE9 (Roche Applied Sci-
ence). For lentivirus infection, mNS-5 cells were
seeded in 60 mm tissue culture plate at a density of
1 × 106 cells per plate. Twenty-four hours later, cells
were infected with lentiviruses in the presence of
8 μg/ml of polybrene (Millipore). Twenty-four hours
after lentivirus infection, the medium was removed and
replaced with fresh medium containing 600 ng/ml puro-
mycin (Gibco) for selection.
RNA isolation and microarray analysis
Three independent biological replicates of nonsilencing
control and Med12-specific shRNA infected cells were
prepared for gene expression microarray analysis. Cells
were harvested 5.5 days after virus infection and total
Fig. 7 Schematic model for the role of Med12 in mNSCs. Med12 contributes to the maintenance of NSC identity through a functionally bipartite
role in suppression and activation of gene expression programs dedicated to cell adhesion and G1/S phase cell cycle progression, respectively
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RNA was isolated using the RNeasy Mini Kit (Qiagen,
Valencia, CA) following the manufacturer’s protocol. RNA
was quantified using a NanoDrop 2000c spectrophotom-
eter, and RNA quality was assessed using Agilent Bioana-
lyzer (Agilent Technologies, Inc., Santa Clara, CA).
Double-stranded cDNA was synthesized from 500 ng total
RNA and subsequently subjected to biotin-labeled cRNA
by llumina® TotalPrep RNA Amplification Kit (Ambion,
Applied Biosystems, Foster City, CA). The quality of
cRNA was assessed using the same way as described
above. Biotinylated cRNA was hybridized onto Illumina
MouseWG-6 BeadChip (Illumina, San Diego, CA) accord-
ing to the manufacturer’s protocol.
Arrays were scanned using Illumina iScan System.
Raw signal intensities of gene expression data were proc-
essed, background subtracted and quantile normalized
using Genome Studio (Illumina). Data was exported
from Genome Studio and combined with annotation file
and experimental parameter file to import into GeneSpring
GX (Agilent) for statistical analysis and visualization (in-
cluding clustering).
Differentially expressed genes (Benjamini-Hochberg
corrected p-value of p ≤ 0.05 and fold change ≥2) were
exported for Ingenuity® Pathway analysis (Ingenuity
Systems, Mountain View, CA) to identify biological
significance of the transcriptional changes observed in
Med12 depleted mNS-5 cells.
Quantitative RT-PCR analysis
Gene expression was measured by quantitative real-time
PCR analysis. Briefly, 1 μg of total RNA extracted from in-
fected mNS-5 cells were subjected to reverse-transcription
using ImProm-II Reverse Transcription System (Promega)
according to the manufacturer’s instruction. Quantitative
PCR was carried out using Applied Biosystems 7900HT
Fast Real-Time PCR system in 10ul reactions containing
5ul of Absolute SYBR Green ROX mix (Applied Biosys-
tems®, Foster City, CA) and each primer at 70 nM. Primers
were synthesized by IDT (Integrative DNA Technologies,
Coralville, IA) and tested for specificity and amplification
efficiency. The sequences of the primers used are listed in
Additional file 4: Table S2. Relative mRNA levels were
calculated using the comparative CT method, as described
by the manufacturer (Applied Biosystems®), using GAPDH
or β-actin Ct values for normalization. Statistical signifi-
cance was evaluated by Student’s t-test.
Cell adhesion assay
Cells were seeded at a concentration of 1 × 106 per
60 mm tissue culture plate. After 24 h, cells were in-
fected with shRNA-expressing lentivirus for 24 h and
subject to puromycin selection as previously described.
Six days post-infection, cells were labeled with calcein
AM (Life Technologies™), and re-seeded on black-walled
96 well plates. After 2-hour incubation at 37 °C, nonad-
herent calcein-labeled cells were removed by washing
and fluorescence was measured using Fluoroskan Ascent
FL (Thermo Scientific). The percentage of adhesion was
determined by dividing the corrected (background sub-
tracted) fluorescence of adherent cells by the total cor-
rected fluorescence of cells added to each microplate
well and multiplying by 100 %.
For knockdown-differentiation-adhesion assays, cells
were seeded at a concentration of 1 × 106 per 60 mm tis-
sue culture plate. After 24 h, cells were infected with
shRNA-expressing lentiviruses for 24 h and then subject
to puromycin selection. Five days post-infection, cells
were re-seeded onto T-75 tissue culture flask and initi-
ated to differentiate toward neuronal lineage. Adhesion
assay was performed 40 h following the start of the neur-
onal differentiation. Brightfield images were obtained by
Nikon Eclipse TE300 inverted optical microscope (Nikon)
1, 4, and 7 days after neuronal differentiation initiation.
Proliferation assay
Cells were seeded at a concentration of 1 × 106 per 60 mm
tissue culture plate. After 24 h, cells were infected with
NS, Med12-, Cdk8-, Med1- specific shRNA-expressing
lentiviruses at 60–70 % confluency and subject to puro-
mycin selection 24 h after virus infection (Gibco, CA,
USA). Cells were re-seeded in triplicate on 12-well plates
4 days post-infection, and proliferation was monitored
using viable cell counting after trypan blue staining 24, 48,
72, and 96 h after re-seeding. Statistical significance was
evaluated by Student’s t-test.
Cell cycle and apoptosis assay
Cells were infected with shRNA-expressing lentivirus at
60–70 % confluency and selected by puromycin 24 h
after virus infection (Gibco, CA, USA). Five days
post-infection, cells were detached using Accutase
(Sigma-Aldrich, St Louis, MO, USA), washed with PBS,
and fixed with 1 ml of ice-cold 70 % ethanol. Following
centrifugation, cells were washed with PBS and stained
with 20 μg/ml PI (Invitrogen) solution in PBS containing
0.1 % Triton X-100 (Sigma-Aldrich, St Louis, MO, USA)
and 0.2 mg/ml DNase-free RNase A (Invitrogen, CA,
USA) and incubated in the dark at 37 °C for 30 min. Cells
were acquired by the FACSCalibur flow cytometer (BD
Bioscience, San Jose, CA) with the CellQuest Pro software
and then analyzed with the FlowJo software (TreeStar
INC, Ashland, OR). PI-Area and PI-Width parameters
were used as doublet discriminators and at least 10,000
single cell events were collected.
For apoptosis, cells were stained with annexin V con-
jugated to APC and propidium iodide (eBioscience, San
Diego, CA) according to the manufacturer’s instructions
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and were acquired on the FACSCalibur within 1 h. The
data was analyzed using the FlowJo software.
Preparation of cell lysate and western blot analysis
Nuclear extracts were prepared in buffer C (20 mM
Hepes pH 7.9, 20 % Glycerol, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.1 % NP-40) supplemented with
protease inhibitors. Lysates were resolved by 10 %-SDS
PAGE, and proteins were analyzed by immunoblot using
antibodies against MED12 (Bethyl), CDK8 (Santa Cruz
Biotechnology), Cyclin C (BD Biosciences), MED1 (Santa
Cruz Biotechnology), MED4 (produced in our laboratory),
MED23 (BD Biosciences), MED30 (produced in our
laboratory), TFIIHp89 (Santa Cruz Biotechnology), TFIIEβ
(Santa Cruz Biotechnology), and TUJ1 (Covance).
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as RNA from an independent set of knockdown experiments (D). Data
represent the mean +/− SEM of at least three independent experiments
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Additional file 2: Table S1. Differentially regulated genes by Med12 KD
in mNS-5 NSCs. (DOCX 100 kb)
Additional file 3: Figure S2. Validation of Med12 and Cdk8 depletion
in representative knockdown experiment. Nuclear extracts from mNS-5
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served as an internal loading control. (TIF 917 kb)
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